InsiderClue
Insiders · Profile

MPM BIOVENTURES 2018, L.P.

10% owner at Entrada Therapeutics · 10% owner at Aktis Oncology. Filing since 2 Nov 2021. CIK 0001729505

TRDA Entrada Therapeutics, Inc. 10% owner · 15 trades AKTS Aktis Oncology, Inc. 10% owner · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
TRDA Entrada Therapeutics, Inc.
9 Sep 2026
10% owner
Sold at will
28,837
$205.61K
0.7%
TRDA Entrada Therapeutics, Inc.
8 Sep 2026
10% owner
Sold at will
192,500
$1.43M
4.7%
TRDA Entrada Therapeutics, Inc.
4 Sep 2026
10% owner
Sold at will
38,500
$273.74K
0.9%
TRDA Entrada Therapeutics, Inc.
3 Sep 2026
10% owner
Sold at will
32,263
$231.33K
0.8%
TRDA Entrada Therapeutics, Inc.
2 Sep 2026
10% owner
Sold at will
25,131
$180.69K
0.6%
TRDA Entrada Therapeutics, Inc.
1 Sep 2026
10% owner
Sold at will
29,088
$205.36K
0.7%
TRDA Entrada Therapeutics, Inc.
31 Aug 2026
10% owner
Sold at will
44,259
$309.37K
1.0%
TRDA Entrada Therapeutics, Inc.
28 Aug 2026
10% owner
Sold at will
3,733
$26.17K
0.1%
TRDA Entrada Therapeutics, Inc.
27 Aug 2026
10% owner
Sold at will
38,922
$280.24K
0.9%
TRDA Entrada Therapeutics, Inc.
26 Aug 2026
10% owner
Sold at will
14,569
$102.86K
0.3%
TRDA Entrada Therapeutics, Inc.
25 Aug 2026
10% owner
Sold at will
26,522
$199.98K
0.6%
TRDA Entrada Therapeutics, Inc.
24 Aug 2026
10% owner
Sold at will
21,623
$158.71K
0.5%
AKTS Aktis Oncology, Inc.
12 Jan 2026
10% owner
Bought
1,112,777
$20.03M
12.2%
TRDA Entrada Therapeutics, Inc.
11 Dec 2024
10% owner
Sold at will
21,787
$440.75K
0.5%
TRDA Entrada Therapeutics, Inc.
10 Dec 2024
10% owner
Sold at will
22,935
$476.36K
0.5%
TRDA Entrada Therapeutics, Inc.
2 Nov 2021
10% owner
Bought
100,000
$2.00M
2.3%
16 decisions on file.